Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2
Author:
Publisher
Elsevier BV
Reference52 articles.
1. Kidney: polycystic kidney disease;Paul;Wiley Interdiscip Rev Dev Biol,2014
2. Current mutation discovery approaches in Retinitis Pigmentosa;Anasagasti;Vision Res,2012
3. Genetics, pathogenesis and complications of osteopetrosis;Del Fattore;Bone,2008
4. RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties;Lu;Heart Rhythm,2013
5. Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder;Leslie Pedrioli;J Invest Dermatol,2012
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Isolation and Generation of Osteoclasts;Methods in Molecular Biology;2025
2. Osteopetrosis and related osteoclast disorders in adults: A review and knowledge gaps On behalf of the European calcified tissue society and ERN BOND;European Journal of Medical Genetics;2024-06
3. Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background;Calcified Tissue International;2024-05-11
4. Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans;Molecular Therapy - Nucleic Acids;2023-09
5. CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs;Frontiers in Bioscience-Landmark;2023-06-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3